Aridis Pharmaceuticals, Inc.

Grantee website Los Gatos, California, United States
Purpose
to develop ultra-low-cost inhaled antibodies that can be readily deployed at large scale to prevent the spread of infectious pathogens in LMIC's
Division
Global Health
Date
OCTOBER 2021
Region served
GLOBAL
Committed amount
$1,933,850
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
15
Grantee location
Los Gatos, California, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.